Xueliang Zhou

Xueliang Zhou

Auto-generated profile, based on publicly available information

Xueliang Zhou

Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China, zzu.edu.cn

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2021 in Bioactive Materials
Verified
Journal Article
Open access
ZLZhaonan Li
Zhaonan Li
CTChuan Tian
Chuan Tian
DJDechao Jiao
Dechao Jiao
JLJing Li
Jing Li
YLYahua Li
Yahua Li
XHXinwei Han
Xinwei Han
Anti-inflammatory and antihyperplasia activities are essential requirements for the successful use of airway stents. In this work, silver nanoparticles (AgNPs) and cisplatin (DDP) were combined in a synergistic modification strategy to improve the surface function of airway stents. Using polycaprolactone (PCL) as a drug carrier, a dual-functional PCL-AgNPs-DDP fiber film-coated airway stent was fabricated by electrospinning. The physicochemical and biological properties of the obtained fiber films were examined. The ATR-FTIR, XPS, SEM-EDS and TEM results suggested that AgNPs and DDP could be successfully immobilized onto the airway stent surface. The drug release and surface degradation results revealed that AgNPs and DDP can undergo sustained release from films for 30 d, and the weight loss was approximately 50% after 35 d. In addition, the dual-functional fiber film suppressed human embryonic lung fibroblast growth and exhibited excellent antibacterial activity against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans. Furthermore, the effectiveness of the dual-functional fiber film-coated airway stent was evaluated by application to the trachea of New Zealand rabbits. The in vivo results indicated that PCL-AgNPs-DDP fiber film-coated airway stent can significantly inhibit granulation tissue formation and collagen deposition, reduced the expression of IL-8, TNF-α, IL-1α, PCNA, α-SMA and CD68, and ultimately achieved anti-inflammatory and antihyperplasia effects. Hence, this study provides a dual-functional surface-coated airway stent to address the clinical complications associated with respiratory tract inflammation and granulation tissue hyperplasia, thus inhibiting tracheal stenosis.

1 December 2021 in International Immunopharmacology
Verified
Journal Article
Closed access
ZLZaoqu Liu
Zaoqu Liu
LLLong Liu
Long Liu
CGChunGuang Guo
ChunGuang Guo
SYSun Yu
Sun Yu
LMLingfang Meng
Lingfang Meng
XHXinwei Han
Xinwei Han

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YYYuan Yao
Yuan Yao
DJDechao Jiao
Dechao Jiao
ZLZaoqu Liu
Zaoqu Liu
JCJianjian Chen
Jianjian Chen
XZXueliang Zhou
Xueliang Zhou
XHXinwei Han
Xinwei Han
Accumulating evidence has demonstrated that microRNAs (miRNAs or miRs) play an important role in the diagnosis and prognosis of tumors. In the case of cholangiocarcinoma (CCA), miRNAs may serve as potential tumor biomarkers and therapeutic targets. Based on The Cancer Genome Atlas (TCGA) database, fold change >2 was used to screen out miRNAs with differential expression in patients with CCA. Univariate and multivariate Cox regression analyses identified miR‐3913‐5p as an independent prognostic factor in patients with CCA. Overall survival and progression‐free survival of patients with CCA were analyzed based on clinical data from TCGA database. In addition, four datasets were combined to identify 21 possible target genes of miR‐3913, and Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses were conducted to predict potential pathways and functions of the molecular target genes. Subsequently, the miRNAs associated with survival were selected to build the miRNA‐mRNA expression network. Furthermore, the differential expression of miR‐3913‐5p in CCA cells and normal bile duct epithelial cells was confirmed through in vitro experiments. The possible target genes (RNF24 and SIGLEC) were further screened by reverse transcription‐quantitative PCR. In addition, functional experiments showed that miR‐3913‐5p might be an oncogene that affects the proliferation and migration of CCA cells by inhibiting and mimicking miR‐3913‐5p. Therefore, miR‐3913 may serve as a biomarker for the diagnosis and prognosis of patients with CCA.

14 August 2021 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
XZXueliang Zhou
Xueliang Zhou
MDMengmeng Dou
Mengmeng Dou
ZLZaoqu Liu
Zaoqu Liu
DJDechao Jiao
Dechao Jiao
ZLZhaonan Li
Zhaonan Li
XHXinwei Han
Xinwei Han
Background. Hepatocellular carcinoma (HCC) remains an important cause of cancer death. The molecular mechanism of hepatocarcinogenesis and prognostic factors of HCC have not been completely uncovered. Methods. In this study, we screened out differentially expressed lncRNAs (DE lncRNAs), miRNAs (DE miRNAs), and mRNAs (DE mRNAs) by comparing the gene expression of HCC and normal tissue in The Cancer Genome Atlas (TCGA) database. DE mRNAs were used to perform Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Then, the miRNA and lncRNA/mRNA modules that were most closely related to the survival time of patients with HCC were screened to construct a competitive endogenous RNA (ceRNA) network by weighted gene coexpression network analysis (WGCNA). Moreover, univariable Cox regression and Kaplan-Meier curve analyses of DE lncRNAs and DE mRNAs were conducted. Finally, the lasso-penalized Cox regression analysis and nomogram model were used to establish a new risk scoring system and predict the prognosis of patients with liver cancer. The expression of survival-related DE lncRNAs was verified by qRT-PCR. Results. A total of 1896 DEmRNAs, 330 DElncRNAs, and 76 DEmiRNAs were identified in HCC and normal tissue samples. Then, the turquoise miRNA and turquoise lncRNA/mRNA modules that were most closely related to the survival time of patients with HCC were screened to construct a ceRNA network by WGCNA. In this ceRNA network, there were 566 lncRNA-miRNA-mRNA regulatory pairs, including 30 upregulated lncRNAs, 16 downregulated miRNAs, and 75 upregulated mRNAs. Moreover, we screened out 19 lncRNAs and 14 hub mRNAs related to prognosis from this ceRNA network by univariable Cox regression and Kaplan-Meier curve analyses. Finally, a new risk scoring system was established by selecting the optimal risk lncRNAs from the 19 prognosis-related lncRNAs through lasso-penalized Cox regression analysis. In addition, we established a nomogram model consisting of independent prognostic factors to predict the survival rate of HCC patients. Finally, the correlation between the risk score and immune cell infiltration and gene set enrichment analysis were determined. Conclusions. In conclusion, the results may provide potential biomarkers or therapeutic targets for HCC and the establishment of the new risk scoring system and nomogram model provides the new perspective for predicting the prognosis of HCC.

15 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YYYuan Yao
Yuan Yao
DJDechao Jiao
Dechao Jiao
ZLZhaonan Li
Zhaonan Li
XZXueliang Zhou
Xueliang Zhou
JLJing Li
Jing Li
XHXinwei Han
Xinwei Han
Exosomes are vesicles with a diameter of 30‐150 nm produced by living cells and secreted into the extracellular matrix. Exosomes mediate cellular communication by carrying active molecules, such as nucleic acids, proteins, and liposomes. Although exosomes are found in various body fluids, little is known about bile‐derived exosomes. This review is the first to summarize the methods of bile storage and isolation of biliary exosomes, highlighting the roles of bile‐derived exosomes, especially exosomal noncoding RNAs, in physiological and disease states and discussing their potential clinical applications.

17 August 2021 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Open access
PDF file
JLJuanfang Liu
Juanfang Liu
WZWenguang Zhang
Wenguang Zhang
HLHuibin Lu
Huibin Lu
HLHongbin Li
Hongbin Li
XZXueliang Zhou
Xueliang Zhou
XHXinwei Han
Xinwei Han
Purpose: To assess the clinical value of drug-eluting bead trans-arterial chemoembolization (DEB-TACE) combined with microwave ablation (MWA) vs. MWA treatment alone for early stage hepatocellular carcinoma (HCC). Materials and methods: Consecutive data from 102 HCC patients at early stage who were referred to our hospital from December 2014 to May 2016 were retrospectively collected. Forty-seven patients underwent DEB-TACE combined with MWA treatment, whereas 55 patients underwent MWA alone. After 1 month of treatment, the tumour responses of the patients were assessed using the mRECIST criteria. Treatment-related complications and hepatic function were also analysed for the two groups. In addition, overall survival (OS) and progression-free survival (PFS) were calculated and compared. Results: Patients in the combined treatment group (DEB-TACE combined with MWA) presented a better objective response rate (ORR) and disease control rate (DCR) compared with those in the monotherapy group (MWA treatment). The median OS and PFS were longer in the combined treatment group compared with the monotherapy group. Multivariate Cox’s regression further illustrated that DEB-TACE + MWA vs. MWA was an independent protective factor for PFS and OS. No serious treatment-related complications were observed in any of the patients. Conclusion: Combined treatment with DEB-TACE appeared to have advantages in prolonging OS and PFS compared to MWA. Therefore, combined treatment was efficient and should be strongly recommended to early stage HCC patients.